NMJ

Neuromuscular Research Group

Neuromuscular Research Group

We study muscle homeostasis and regeneration under normal and pathologic conditions. The main goal of our project is to define the tissue signals and to characterize the molecular mechanisms of muscle wasting. Although considerable information has accumulated regarding the physiopathology of muscle diseases, the associated molecular mechanisms are still poorly understood.

Muscle expression of SOD1(G93A) triggers the dismantlement of neuromuscular junction via PKC-theta

AIM:
Neuromuscular junction (NMJ) represents the morphofunctional interface between muscle and nerve. Several chronic pathologies such as aging and neurodegenerative diseases, including muscular dystrophy and amyotrophic lateral sclerosis, display altered NMJ and functional denervation. However, the triggers and the molecular mechanisms underlying the dismantlement of NMJ remain unclear.
RESULTS:

Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: results of a randomized, double-blind, controlled study

The aim of the study was to verify whether neuromuscular magnetic stimulation (NMMS) improves muscle function in spinal-onset amyotrophic lateral sclerosis (ALS) patients. Twenty-two ALS patients
were randomized in two groups to receive, daily for two weeks, NMMS in right or left arm (referred to as real-NMMS, rNMMS), and sham NMMS (sNMMS) in the opposite arm. All the patients underwent a

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma